Halozyme Therapeutics (HALO) FCF Margin (2010 - 2026)
Halozyme Therapeutics (HALO) reported FCF Margin of 49.21% for Q2 2026, up 19.08 percentage points from 30.13% a year earlier and up 2.40 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) FCF Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' FCF Margin came in at 48.46%, up 2.59 percentage points year-over-year; for FY2025, it came in at 46.15%, up 0.02 percentage points from FY2024.
- FCF Margin has increased for three consecutive years, with a five-year change of +26.37 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at 46.13% in FY2024 (+1.12 pp), 45.01% in FY2023 (+9.37 pp), 35.65% in FY2022 (-31.57 pp) and 67.22% in FY2021 (+47.43 pp).
- Five-year quarterly FCF Margin spans a low of 23.00% in Q2 2024 and a high of 104.67% in Q3 2021.
- Year over year, FCF Margin gained in four of the last eight quarters, with an average year-over-year change of +0.40 percentage points.
- The high point for year-over-year FCF Margin in five years was Q3 2021 (a gain of 95.63 percentage points); the low point was Q3 2022 (a drop of 71.83 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 46.81% (Q1 2026), 48.17% (Q4 2025) and 49.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn | 49.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.21% |
| Mar 31, 2026 | 46.81% |
| Dec 31, 2025 | 48.17% |
| Sep 30, 2025 | 49.56% |
| Jun 30, 2025 | 30.13% |
| Mar 31, 2025 | 57.87% |
| Dec 31, 2024 | 58.86% |
| Sep 30, 2024 | 39.25% |
| Jun 30, 2024 | 23.00% |
| Mar 31, 2024 | 64.27% |
| Dec 31, 2023 | 43.37% |
| Sep 30, 2023 | 59.93% |
| Jun 30, 2023 | 30.97% |
| Mar 31, 2023 | 46.62% |
| Dec 31, 2022 | 44.14% |
| Sep 30, 2022 | 32.84% |
| Jun 30, 2022 | 25.77% |
| Mar 31, 2022 | 40.34% |
| Dec 31, 2021 | 80.74% |
| Sep 30, 2021 | 104.67% |
API Access
Halozyme Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();